Skip to main content
Clinical Trials/NCT02832921
NCT02832921
Unknown
Not Applicable

Cognitive-motor Intervention Using Virtual Reality for Middle-aged Individuals at High Dementia Risk

Sheba Medical Center1 site in 1 country200 target enrollmentJuly 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Alzheimer's Disease (AD)
Sponsor
Sheba Medical Center
Enrollment
200
Locations
1
Primary Endpoint
change in overall cognition- measured by averaging z-scores from 14 paper and pencil neuropsychological tests covering episodic memory and executive functions cognitive domains.
Last Updated
8 years ago

Overview

Brief Summary

The primary objective of this program is to apply a virtual reality (VR) cognitive-motor intervention (compared to active and passive control groups) to delay or slow cognitive decline of middle-aged adults who have a family history of Alzheimer's disease (AD) and thus are at particularly high risk of developing the disease.

Registry
clinicaltrials.gov
Start Date
July 2016
End Date
August 2019
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • The participants of the study must have at least one parent with Alzheimer's disease.
  • Fluency in Hebrew, in order to understand the instructions of the cognitive tests.
  • Availability of an informant for the participant.

Exclusion Criteria

  • Severe neurological or psychological conditions that may affect cognitive performance.
  • Substantial orthopedic limitations which prevent the use of treadmill.
  • Unstable medical condition such as an active cancer.
  • Incapability of adherence to the training program.
  • The participant is undergoing a treatment that may interfere with the study program.

Outcomes

Primary Outcomes

change in overall cognition- measured by averaging z-scores from 14 paper and pencil neuropsychological tests covering episodic memory and executive functions cognitive domains.

Time Frame: baseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group)

summary of the z-scores of all 14 paper and pencil cognitive tests

change in cerebral blood flow from arterial spin labeling (ASL)

Time Frame: baseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group)

acquired by structural MRI using background-suppressed pseudo-continuous ASL (pcASL) featuring a 3D fast spin echo spiral sequence

Secondary Outcomes

  • hippocampal volume(baseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group))
  • frontal inferior cortex volume(baseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group))
  • white matter hyperintensity (WMH) burden(baseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group))
  • specific cognitive domains- average of z-scores of paper and pencil memory tests and of executive functions tests(baseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group))
  • blood oxygenation level dependent (BOLD) functional MRI (fMRI) signal in the fronto-parietal network associated with working memory(baseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group))
  • brain resting state functional connectivity by resting state network fMRI BOLD signal correlations(baseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group))
  • diffusion-tensor imaging (DTI) measures(baseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group))

Study Sites (1)

Loading locations...

Similar Trials